Evidence map›Paper›PMID 33535705›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Identification of a Depolymerase Specific for K64-Serotype

Jiayin Li, Yueying Sheng, Ruijing Ma, Mengsha Xu, Fuli Liu, Rong Qin, Mingxi Zhu, Xianchao Zhu, Ping He

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Phage and endolysin-based inhibition ofFrontiers in cellular and infection microbiology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Identification and functional characterization of a novelFrontiers in cellular and infection microbiology · 2025
    Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. A 24-year longitudinal study ofEpidemiology and infection · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jiayin LiDepartment of Medical Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Yueying ShengCollege of Medical Technology, Shanghai University of Medicine & Health Sciences, Shanghai 201318, China.
Ruijing MaShanghai Ruizhou Biotech Co. Ltd., Pudong New District, Shanghai 201203, China.
Mengsha XuDepartment of Medical Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.ORCID 0000-0002-0534-5716
Fuli LiuDepartment of Medical Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Rong QinDepartment of Medical Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Mingxi ZhuDepartment of Medical Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Xianchao ZhuShanghai Ruizhou Biotech Co. Ltd., Pudong New District, Shanghai 201203, China.
Ping HeDepartment of Medical Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Funding

he National Natural Science Foundation of China 81971896the Natural Science Foundation of Shanghai Program 19ZR1428600
6 · The paper itself

Abstract

Carbapenem-resistant

Indexed as

antivirulencebacteriophagecapsular depolymerasecapsular typingKlebsiella pneumoniae

Identifiers

PMID33535705
PMCPMC7912862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.